David W. Dowdy, MD
B. Frank and Kathleen Polk Assistant Professor
Division: Infectious Disease Epidemiology
615 N. Wolfe St., E6531
Baltimore , Maryland 21205
TB Modeling Group: http://modeltb.org
MD , Johns Hopkins School of Medicine , 2008
PhD , Johns Hopkins BSPH
ScM , Johns Hopkins BSPH
I am a junior investigator in the field of infectious disease epidemiology, and also a practicing general internist. My interdisciplinary research lies at the nexus of infectious disease modeling, health economics, operational and implementation science, and classical epidemiology. My primary interests are:
(1) Modeling of TB and TB/HIV: My greatest research passion is evaluating the implementation and scale-up of TB and HIV control interventions, especially diagnostic and case-finding strategies. I combine methods from traditional epidemiology, cost-effectiveness analysis, and epidemic modeling with the aim of answering questions of relevance to patients and policy-makers. I serve on the steering committee of the Gates Foundation-funded TB-Modeling and Analysis Consortium (TB-MAC) and direct two NIH-funded projects related to modeling the scale-up of TB diagnostic tests. I currently work with collaborators on projects based in Malawi, South Africa, Uganda, India, Bangladesh, Brazil, Canada, and the United States.
(2) Translational epidemiology: I have great interest in creating modeling frameworks that allow decision-makers to translate epidemiological data into effective decisions. I welcome collaboration from researchers, clinicians, or students having expertise in any field, who hope to create models to translate epidemiological data into meaningful policy, practical, or clinical decisions.
(3) Clinical epidemiology and patient-important outcomes: I am interested in evaluating outcomes of relevance to patients, including quality and duration of life. Specifically, I work with a cohort study of ICU survivors in Baltimore to investigate long-term outcomes, including strength and quality of life, after critical illness. I feel strongly about creating closer ties between the worlds of clinical practice and epidemiology.
(4) Teaching and mentorship: These are essential, and often-undervalued, skills in the field of epidemiology. If our profession is to continue its record of success, I firmly believe that we need to train future leaders how to teach and mentor others, and also to do our best to serve as role models in that regard.
Honors and Awards
Awards since 2008:
2013 Advising, Mentoring, and Teaching Recognition Award (AMTRA), JHSPH
2012 B. Frank and Kathleen Polk Assistant Professor of Epidemiology
2012 Young Investigator Prize, International Union Against Tuberculosis and Lung Disease
2011 Tom Evans Teaching Award, Internal Medicine Residency Program, UCSF
2010 Diane Becker Award in Clinical Epidemiology and Prevention, Johns Hopkins GIM Housestaff Research Award
2010 Floyd Rector Clinical Science Research Award, Internal Medicine Residency Program, UCSF
2010 Teaching Excellence Award for Cherished Housestaff (TEACH), UCSF School of Medicine
2009 Julius Krevans Award for Outstanding Housestaff Service, San Francisco General Hospital
2008 Warfield T. Longcope Prize in Clinical Medicine, Johns Hopkins University School of Medicine
2008 David E. Rogers Award for Professionalism, Ethics, & Community, Johns Hopkins University School of Medicine
2008 Alpha Omega Alpha Honor Society
2008 Arthur M. Dannenberg, Jr. Award for Tuberculosis Research
infectious diseases, tuberculosis, HIV, epidemiology, mathematical modeling, health economics
Nachega JB, Parienti JJ, Uthman OA, Gross R, Dowdy DW, et al. Lower Pill Burden and Once-daily Dosing Antiretroviral Treatment Regimens for HIV Infection: A Meta-Analysis of Randomized Controlled Trials. Clin Infect Dis. 2014 Jan 22. [Epub ahead of print]
Theron G, Peter J, Dowdy D, et al. Do high rates of empirical treatment undermine the potential effect of new diagnostic tests for tuberculosis in high-burden settings? Lancet Infect Dis. 2014 Jan 14 [Epub ahead of print]
Denkinger CM, Pai M, Dowdy DW. Do we need to detect isoniazid resistance in addition to rifampicin resistance in diagnostic tests for tuberculosis? PLoS ONE. 2014 Jan 3;9(1):e84197.
Pai M, Denkinger CM, Kik SV, Rangaka MX, Zwerling A, Oxlade O, Metcalfe JZ, Cattamanchi A, Dowdy DW, Dheda K, Banaei N. Gamma Interferon Release Assays for Detection of Mycobacterium tuberculosis Infection. Clin Microbiol Rev. 2014 Jan;27(1):3-20.
Schroeder LF, Robilotti E, Peterson LR, Banaei N, Dowdy DW. Economic Evaluation of Laboratory Testing Strategies for Hospital-Associated Clostridium difficile Infection. J Clin Microbiol. 2014 Feb;52(2):489-96.
Publications from Jan-Feb 2014: